Cardiovascular disease continues to be the leading cause of death worldwide. But advances in heart-failure therapeutics have ...

Cytokinetics ( ($CYTK) ) has released its Q3 earnings. Here is a breakdown of the information Cytokinetics presented to its investors.

Interested parties may access the live webcasts of the fireside chats by visiting the Investors & Media section of the Cytokinetics website at https://www.cytokinetics.com. The webcast replays will be ...

Interactions with FDA Progressing Towards December 26, 2025 PDUFA Date for Aficamten; U.S. Commercial Launch Preparations on TrackEx-U.S.

Cardiac complications in Duchenne muscular dystrophy (DMD) are the result of cardiac muscle involvement that accompanies the deterioration of skeletal muscle in the disease. The use of ...

—Starting cardiac medications, using the proper timing and dosing, to optimize the efficacy of therapies and improve patient outcomes, is key to cardiac care for patients with Duchenne muscular ...

Researchers have investigated the effect of increased cell temperature on the contractility of skeletal muscle and cardiac muscle by heating the muscle proteins using advanced microscopical techniques ...

Regenerative heart therapies involve transplanting cardiac muscle cells into damaged areas of the heart to recover lost function. However, the risk of arrhythmias following this procedure is ...

Find out what the key differences between a heart attack and cardiac arrest are so that you can respond quickly and correctly ...